FDA Adverse Event Injury Summary report: N

IMPLANTABLE INFUSION PUMP

MDR report key: 5673052 · Received May 23, 2016

Report

Report Number
3007566237-2016-02076
Event Type
Injury
Date Received
May 23, 2016
Date of Event
February 26, 2016
Report Date
May 23, 2016
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
LKK
PMA / PMN Number
P860004
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE REPORTED AGE REFLECTS THE AVERAGE AGE OF THE PATIENTS REPORTED IN THE LITERATURE ARTICLE. THE REPORTED SEX REFLECTS THAT OF THE MAJORITY OF THE PATIENTS REPORTED IN THE LITERATURE ARTICLE. IT WAS NOT POSSIBLE TO MATCH THIS EVENT WITH ANY PREVIOUSLY REPORTED EVENT. OTHER APPLICABLE COMPONENTS ARE: PRODUCT ID: NEU_UNKNOWN_PUMP, LOT# UNKNOWN, PRODUCT TYPE: PUMP. PRODUCT ID: NEU_UNKNOWN_CATH, LOT# UNKNOWN, PRODUCT TYPE: CATHETER.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

SPADER, H.S., BOLLO, R.J., BOWERS, C.A., RIVA-CAMBRIN, J. RISK FACTORS FOR BACLOFEN PUMP INFECTION IN CHILDREN: A MULTIVARIATE ANALYSIS. JOURNAL OF NEUROSURGERY. PEDIATRICS. 2016:1-7. DOI: 10.3171/2015.11.PEDS15421. SUMMARY: INTRATHECAL BACLOFEN INFUSION SYSTEMS TO MANAGE SEVERE SPASTICITY AND DYSTONIA ARE ASSOCIATED WITH HIGHER INFECTION RATES IN CHILDREN THAN IN ADULTS. FACTORS UNIQUE TO THIS POPULATION, SUCH AS POOR NUTRITION AND PHYSICAL LIMITATIONS FOR PUMP PLACEMENT, HAVE BEEN HYPOTHESIZED AS THE REASONS FOR THIS DISPARITY. THE AUTHORS ASSESSED POTENTIAL RISK FACTORS FOR INFECTION IN A MULTIVARIATE ANALYSIS. REPORTED EVENTS: SIX PATIENTS HAD EITHER SUPERFICIAL OR DEEP WOUND DEHISCENCE. ONE PATIENT HAD WOUND DEHISCENCE AND EROSION WITH VISIBLE HARDWARE. THIS PATIENT WAS CONSIDERED TO BE INFECTED BUT DID NOT HAVE A POSITIVE CULTURE. TEN PATIENTS HAD CEREBROSPINAL FLUID (CSF) LEAK. FIVE OF THE INFECTIONS WERE METHICILLIN-RESISTANT STAPH AUREUS. ELEVEN OF THE INFECTIONS WERE METHICILLIN-SENSITIVE STAPH AUREUS. TWO OF THE INFECTIONS WERE STAPH EPIDERMIS. ONE INFECTION WAS STAPH CAPITAS. TWO INFECTIONS WERE DUE TO PSEUDOMONAS SPECIES. ONE INFECTION WAS DUE TO PROPIONIBACTERIUM ACNES. ONE INFECTION WAS DUE TO ENTEROCOCCUS FAECALIS. ONE INFECTION WAS DUE TO GRAM-NEGATIVE BACILLI. REVISIONS WITHIN 6 MONTHS OF PUMP PLACEMENT WERE ALL ASSOCIATED WITH HIGHER INFECTION RATES. THE CAUSE OF THE REVISIONS WERE NOT NOTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
328549 IMPLANTABLE INFUSION PUMP PUMP, INFUSION, IMPLANTED, PROGRAMMABLE LKK MEDTRONIC NEUROMODULATION NEU_UNKNOWN_PUMP UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 9 YR Required Intervention